Regulation of EMT by KLF4 in gastrointestinal cancer

Current Cancer Drug Targets

Volumn 13, Issue 9, 2013, Pages 986-995

  Cui, Jiujie ^a,c   Shi, Min ^b,c   Quan, Ming ^a,c   Xie, Keping ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

EMT; Gastrointestinal cancer; KLF4; Notch; TGF ; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; CALVASCULIN; CLAUDIN 1; CLAUDIN 7; CYCLIN B1; CYCLIN D1; CYTOKERATIN 4; GOOSECOID PROTEIN; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MICRORNA 10B; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN;

APOPTOSIS; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; COLON POLYPOSIS; DIGESTIVE SYSTEM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GOBLET CELL; HUMAN; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOGENESIS; EPITHELIAL-MESENCHYMAL TRANSITION; GASTROINTESTINAL NEOPLASMS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; SIGNAL TRANSDUCTION;

EID: 84890828632     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113136660104     Document Type: Review

References (103)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2), 69-90.
2. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62(1), 10-29.
3. Thompson, E. W.; Torri, J.; Sabol, M.; Sommers, C. L.; Byers, S.; Valverius, E. M.; Martin, G. R.; Lippman, M. E.; Stampfer, M. R.; Dickson, R. B. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis 1994, 12(3), 181-194.
4. Savagner, P.; Boyer, B.; Valles, A. M.; Jouanneau, J.; Thiery, J. P. Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat. Res. 1994, 71, 229-249.
5. Wei, D.; Kanai, M.; Huang, S.; Xie, K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 2006, 27(1), 23-31.
6. Lehembre, F.; Yilmaz, M.; Wicki, A. Schomber, T.; Strittmatter, K.; Ziegler, D.; Kren, A.; Went, P.; Derksen, P. W.; Berns, A.; Jonkers, J.; Christofori, G. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 2008, 27(19), 2603-2615.
7. Mjaatvedt, C. H.; Markwald, R. R. Induction of an epithelialmesenchymal transition by an in vivo adheron-like complex. Dev. Biol. 1989, 136(1), 118-128.
8. Colas, E.; Pedrola, N.; Devis, L. Ertekin, T.; Campoy, I.; Martínez, E.; Llauradó, M.; Rigau, M.; Olivan, M.; Garcia, M.; Cabrera, S.; Gil-Moreno, A.; Xercavins, J.; Castellvi, J.; Garcia, A.; Ramon y Cajal, S.; Moreno-Bueno, G.; Dolcet, X.; Alameda, F.; Palacios, J.; Prat, J.; Doll, A.; Matias-Guiu, X.; Abal, M.; Reventos, J. The EMT signaling pathways in endometrial carcinoma. Clin. Transl. Oncol. 2012, 14(10), 715-720.
9. Heldin, C. H.; Vanlandewijck, M.; Moustakas, A. Regulation of EMT by TGFbeta in cancer. FEBS Lett. 2012, 586(14), 1959-1970.
10. Harris, T. J.; Tepass, U. Adherens junctions: from molecules to morphogenesis. Nat. Rev. Mol. Cell Biol. 2010, 11(7), 502-514.
11. van Zijl, F.; Krupitza, G.; Mikulits, W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat. Res. 2011, 728(1-2), 23-34.
12. Xing, X.; Tang, Y. B.; Yuan, G.; Wang, Y.; Wang, J.; Yang, Y.; Chen, M. The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int. J. Cancer 2013, 132(11), 2589-2596.
13. Xu, X. L.; Ling, Z. Q.; Chen, S. Z.; Li, B.; Ji, W. H.; Mao, W. M. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Dis Esophagus 2013. doi: 10.1111/dote.12024. [Epub ahead of print]
14. Chen, X.; Wang, Y.; Xia, H.; Wang, Q.; Jiang, X.; Lin, Z.; Ma, Y.; Yang, Y.; Hu, M. Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol. Biol. Rep. 2012, 39(6), 6707-6714.
15. Puhalla, H.; Herberger, B.; Soleiman, A.; Filipits, M.; Laengle, F.; Gruenberger, T.; Wrba, F. E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue. Anticancer Res. 2005, 25(6B), 4249-4254.
16. Jiang, X. M.; Zhang, J. B.; Xiong, J.; Huang, X. X.; Ren, Z. G.; Altered distribution and expression pattern of E-cadherin in hepatocellular carcinomas: correlations with prognosis and clinical features. Asian Pac. J. Cancer Prev. 2012, 13(12), 6455-6461.
17. Karayiannakis, A. J.; Syrigos, K. N.; Chatzigianni, E.; Papanikolaou, S.; Alexiou, D.; Kalahanis, N.; Rosenberg, T.; Bastounis, E. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res. 1998, 18(6A), 4177-4180.
18. Derycke, L. D.; Bracke, M. E. N-cadherin in the spotlight of cellcell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 2004, 48(5-6), 463-476.
19. Huang, C.; Qiu, Z.; Wang, L.; Peng, Z.; Jia, Z.; Logsdon, C. D.; Le, X.; Wei, D.; Huang, S.; Xie, K. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012, 72(3), 655-665.
20. Christofori, G. New signals from the invasive front. Nature 2006, 441(7092), 444-450.
21. Thiery, J. P.; Acloque, H.; Huang, R. Y.; Nieto, M. A. Epithelialmesenchymal transitions in development and disease. Cell 2009, 139(5), 871-890.
22. Yang, J.; Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14(6), 818-829.
23. Rathinam, R.; Berrier, A.; Alahari, S. K. Role of Rho GTPases and their regulators in cancer progression. Front Biosci. 2011, 16, 2561-2571.
24. Bieker, J. J. Kruppel-like factors: three fingers in many pies. J. Biol. Chem. 2001, 276(37), 34355-34358.
25. Philipsen, S.; Suske, G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999, 27(15), 2991-3000.
26. Suske, G.; Bruford, E.; Philipsen, S. Mammalian SP/KLF transcription factors: bring in the family. Genomics 2005, 85(5), 551-556.
27. Shields, J. M.; Christy, R. J.; Yang, V. W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 1996, 271(33), 20009-20017.
28. Garrett-Sinha, L. A.; Eberspaecher, H.; Seldin, M. F.; de Crombrugghe, B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 1996, 271(49), 31384-31390.
29. Yet, S. F.; McA'Nulty, M. M.; Folta, S. C.; Yen, H. W.; Yoshizumi, M.; Hsieh, C. M.; Layne, M. D.; Chin, M. T.; Wang, H.; Perrella, M. A.; Jain, M. K.; Lee, M. E. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol Chem. 1998, 273(2), 1026-1031.
30. Shields, J. M.; Yang, V. W. Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor. Nucleic Acids Res. 1998, 26(3), 796-802.
31. Yanagida, A.; Sogawa, K.; Yasumoto, K. I.; Fujii-Kuriyama, Y. A novel cis-acting DNA element required for a high level of inducible expression of the rat P-450c gene. Mol Cell Biol. 1990, 10(4), 1470-1475.
32. Yang, Y.; Goldstein, B. G.; Chao, H. H.; Katz, J. P. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther. 2005, 4(11), 1216-1221.
33. Wang, N.; Liu, Z. H.; Ding, F.; Wang, X. Q.; Zhou, C. N.; Wu, M. Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer. World J. Gastroenterol. 2002, 8(6), 966-970.
34. Luo, A.; Kong, J.; Hu, G. Liew, C. C.; Xiong, M.; Wang, X.; Ji, J.; Wang, T.; Zhi, H.; Wu, M.; Liu, Z. Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004, 23(6), 1291-1299.
35. Wei, D.; Gong, W.; Kanai, M.; Schlunk, C.; Wang, L.; Yao, J. C.; Wu, T. T.; Huang, S.; Xie, K. Drastic down-regulation of Kruppellike factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005, 65(7), 2746-2754.
36. Zhang, N.; Zhang, J.; Wang, Z. W.; Zha, L.; Huang, Z. Altered expression of Kruppel-like factor 4 and beta-catenin in human gastric cancer. Oncol. Lett. 2012, 3(5), 1017-1022.
37. Dang, D. T.; Bachman, K. E.; Mahatan, C. S.; Dang, L. H.; Giardiello, F. M.; Yang, V. W. Decreased expression of the gutenriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett. 2000, 476(3), 203-207.
38. Choi, B. J.; Cho, Y. G.; Song, J. W.; Kim, C. J.; Kim, S. Y.; Nam, S. W.; Yoo, N. J.; Lee, J. Y.; Park, W. S. Altered expression of the KLF4 in colorectal cancers. Pathol. Res. Pract. 2006, 202(8), 585-589.
39. Patel, N. V.; Ghaleb, A. M.; Nandan, M. O.; Yang, V. W. Expression of the tumor suppressor Kruppel-like factor 4 as a prognostic predictor for colon cancer. Cancer Epidemiol. Biomarkers Prev. 2010, 19(10), 2631-2638.
40. Li, Q.; Gao, Y.; Jia, Z.; Mishra, L.; Guo, K.; Li, Z.; Le, X.; Wei, D.; Huang, S.; Xie, K. DysregulatedKruppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology 2012, 143(3), 799-810. e1-2.
41. Zhang, W.; Geiman, D. E.; Shields, J. M.; Dang, D. T.; Mahatan, C. S.; Kaestner, K. H.; Biggs, J. R.; Kraft, A. S.; Yang, V. W. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 2000, 275(24), 18391-18398.
42. Ton-That, H.; Kaestner, K. H.; Shields, J. M.; Mahatanankoon, C. S.; Yang, V. W. Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett. 1997, 419(2-3), 239-243.
43. Dang, D. T.; Chen, X.; Feng, J.; Torbenson, M.; Dang, L. H.; Yang, V. W. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 2003, 22(22), 3424-3430.
44. Li, Q.; Jia, Z.; Wang, L.; Kong, X.; Li, Q.; Guo, K.; Tan, D.; Le, X.; Wei, D.; Huang, S.; Mishra, L.; Xie, K. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 2012, 142(3), 531-542.
45. Koo, C. Y.; Muir, K. W.; Lam, E. W. FOXM1: From cancer initiation to progression and treatment. Biochim. Biophys. Acta 2012, 1819(1), 28-37.
46. Kong, X.; Li, L.; Li, Z.; Le, X.; Huang, C.; Jia, Z.; Cui, J.; Huang, S.; Wang, L.; Xie, K. Dysregulated expression of FOXM1 isoforms drive progression of pancreatic cancer. Cancer Res. 2013, 73(13), 3987-3996.
47. Katz, J. P.; Perreault, N.; Goldstein, B. G.; Actman, L.; McNally, S. R.; Silberg, D. G.; Furth, E. E.; Kaestner, K. H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005, 128(4), 935-945.
48. Katz, J. P.; Perreault, N.; Goldstein, B.G.; Lee, C. S.; Labosky, P. A.; Yang, V. W.; Kaestner, K. H. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002, 129(11), 2619-2628.
49. Ghaleb, A. M.; McConnell, B. B.;Nandan, M. O.; Katz, J. P.; Kaestner, K. H.; Yang, V. W. Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res. 2007, 67(15), 7147-7154.
50. Tian, Y.; Luo, A.; Cai, Y.; Su, Q.; Ding, F.; Chen, H.; Liu, Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol Chem. 2010, 285(11), 7986-7994.
51. Dang, D. T.; Mahatan, C. S.; Dang, L. H.; Agboola, I. A.; Yang, V. W. Expression of the gut-enriched Kruppel-like factor (Kruppellike factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 2001, 20(35), 4884-4890.
52. Zhao, W.; Hisamuddin, I. M.; Nandan, M. O.; Babbin, B. A.; Lamb, N. E.; Yang, V. W. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004, 23(2), 395-402.
53. Chen, Z. Y.; Wang, X.; Zhou, Y.; Offner, G.; Tseng, C. C. Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res. 2005, 65(22), 10394-10400.
54. Zhang, G.; Zhu, H.; Wang, Y.; Yang, S.; Liu, M.; Zhang, W.; Quan, L.; Bai, J.; Liu, Z.; Xu, N. Kruppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines. Biol Chem. 2009, 390(5-6), 463-469.
55. Li, D.; Peng, Z.; Tang, H.; Wei, P.; Kong, X.; Yan, D.; Huang, F.; Li, Q.; Le, X.; Li, Q.; Xie, K. KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin. Cancer Res. 2011, 17(11), 3558-3568.
56. Yu, T.; Chen, X.; Zhang, W.; Colon, D.; Shi, J.; Napier, D.; Rychahou, P.; Lu, W.; Lee, E. Y.; Weiss, H. L.; Evers, B. M.; Liu, C. Regulation of the potential marker for intestinal cells, Bmi1, by beta-catenin and the zinc finger protein KLF4: implications for colon cancer. J. Biol. Chem. 2012, 287(6), 3760-3768.
57. Chen, X.; Johns, D. C.; Geiman, D. E. Marban E, Dang DT, Hamlin G, Sun R, Yang VW. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 2001, 276(32), 30423-30428.
58. Yoon, H. S.; Chen, X.; Yang, V. W. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 2003, 278(4), 2101-2105.
59. Yoon, H. S.; Yang, V. W. Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J. Biol. Chem. 2004, 279(6), 5035-5041.
60. Malumbres, M.; Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9(3), 153-166.
61. Nickenig, G.; Baudler, S.; Muller, C.; Werner, C.; Werner, N.; Welzel, H.; Strehlow, K.; Böhm, M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J. 2002, 16(9), 1077-1086.
62. Traka, M. H.; Chambers, K. F.; Lund, E. K.;Goodlad, R. A.; Johnson, I. T.;Mithen, R. F. Involvement of LF4 in sulforaphaneand iberin-mediated induction of p21(waf1/cip1). Nutr. Cancer 2009, 61(1), 137-145.
63. Wei, D.; Kanai, M.; Jia, Z.; Le, X.; Xie, K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res. 2008, 68(12), 4631-4639.
64. Wei, D.; Wang, L.; Kanai, M.; Jia, Z.; Le, X.; Li, Q.; Wang, H.; Xie, K. KLF4alpha up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 2010, 139(6), 2135-2145.
65. Shie, J. L.; Chen, Z. Y.; Fu, M.; Pestell, R. G.; Tseng, C. C. Gutenriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 2000, 28(15), 2969-2976.
66. Chen, Z. Y.; Shie, J. L.; Tseng, C. C. Gut-enriched Kruppel-like factor represses ornithine decarboxylase gene expression and functions as checkpoint regulator in colonic cancer cells. J. Biol. Chem. 2002, 277(48), 46831-46839.
67. Yoon, H. S.; Ghaleb, A. M.; Nandan, M. O.; Hisamuddin, I. M.; Dalton, W. B.; Yang, V. W. Kruppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage. Oncogene 2005, 24(25), 4017-4025.
68. Foster, K. W.; Ren, S.; Louro, I. D.; Lobo-Ruppert, S. M.; McKie-Bell, P.; Grizzle, W.; Hayes, M. R.; Broker, T. R.; Chow, L. T.; Ruppert, J. M. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 1999, 10(6), 423-434.
69. Foster, K. W.; Frost, A. R.; McKie-Bell, P.; Lin, C. Y.; Engler, J. A.; Grizzle, W. E.; Ruppert, J. M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 2000, 60(22), 6488-6495.
70. Pandya, A. Y.; Talley, L. I.; Frost, A. R.; Fitzgerald, T. J.; Trivedi, V.; Chakravarthy, M.; Chhieng, D. C.; Grizzle, W. E.; Engler, J. A.; Krontiras, H.; Bland, K. I.; LoBuglio, A. F.; Lobo-Ruppert, S. M.; Ruppert, J. M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 2004, 10(8), 2709-2719.
71. Rowland, B. D.; Peeper, D. S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 2006, 6(1), 11-23.
72. Segre, J. A.; Bauer, C.; Fuchs, E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22(4), 356-360.
73. Chen, X.; Whitney, E. M.; Gao, S. Y.; Yang, V. W. Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J. Mol. Biol. 2003, 326(3), 665-677.
74. Jenkins, T. D.; Opitz, O. G.; Okano, J.; Rustgi, A. K. Transactivation of the human keratin 4 and Epstein-Barr virus EDL2 promoters by gut-enriched Kruppel-like factor. J. Biol. Chem. 1998, 273(17), 10747-10754.
75. Brembeck, F. H.; Rustgi, A. K. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J. Biol. Chem. 2000, 275(36), 28230-28239.
76. Hinnebusch, B. F.; Siddique, A.; Henderson, J. W.; Malo, M. S.; Zhang, W.; Athaide, C. P.; Abedrapo, M. A.; Chen, X.; Yang, V. W.; Hodin, R. A. Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppellike factor. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286(1), 23-30.
77. Flandez, M.; Guilmeau, S.; Blache, P.; Augenlicht, L. H. KLF4 regulation in intestinal epithelial cell maturation. Exp. Cell Res. 2008, 314(20), 3712-3723.
78. Okita, K.; Yamanaka, S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2011, 366(1575), 2198-2207.
79. Leng, Z.; Tao, K.; Xia, Q.; Tan, J.; Yue, Z.; Chen, J.; Xi, H.; Li, J.; Zheng, H. Kruppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS One 2013, 8(2), e56082.
80. De Craene, B.; Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 2013, 13(2), 97-110.
81. Yori, J. L.; Seachrist, D. D.; Johnson, E.; Lozada, K. L.; Abdul-Karim, F. W.; Chodosh, L. A.; Schiemann, W. P.; Keri, R. A. Kruppellike factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 2011, 13(7), 601-610.
82. Lin, Z. S.; Chu, H. C.; Yen, Y. C.; Lewis, B. C.; Chen, Y. W. Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One 2012, 7(8), e43593.
83. Tiwari, N.; Meyer-Schaller, N.; Arnold, P.; Antoniadis, H.; Pachkov, M.; van Nimwegen, E.; Christofori, G. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One 2013, 8(2), e57329.
84. Koopmansch, B.; Berx, G.; Foidart, J. M.; Gilles, C.; Winkler, R. Interplay between KLF4 and ZEB2/SIP1 in the regulation of Ecadherin expression. Biochem. Biophys. Res. Commun. 2013, 431(4), 652-657.
85. Li, R.; Liang, J.; Ni, S.; Zhou, T.; Qing, X.; Li, H.; He, W.; Chen, J.; Li, F.; Zhuang, Q.; Qin, B.; Xu, J.; Li, W.; Yang, J.; Gan, Y.; Qin, D.; Feng, S.; Song, H.; Yang, D.; Zhang, B.; Zeng, L.; Lai, L.; Esteban, M. A.; Pei, D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 2010, 7(1), 51-63.
86. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113(6), 685-700.
87. Katsuno, Y.; Lamouille, S.; Derynck, R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 2013, 25(1), 76-84.
88. Liu, Y. N.; Abou-Kheir, W.; Yin, J. J.; Fang, L.; Hynes, P.; Casey, O.; Hu, D.; Wan, Y.; Seng, V.; Sheppard-Tillman, H.; Martin, P.; Kelly, K. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelialmesenchymal transition. Mol. Cell Biol. 2012, 32(5), 941-953.
89. Hu, D.; Wan, Y. Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling. J. Biol Chem. 2011, 286(9), 6890-6901.
90. Li, H. X.; Han, M.; Bernier, M.; Zheng, B.; Sun, S. G.; Su, M.; Zhang, R.; Fu, J. R.; Wen, J. K. Kruppel-like factor 4 promotes differentiation by transforming growth factor-beta receptormediated Smad and p38 MAPK signaling in vascular smooth muscle cells. J. Biol Chem. 2010, 285(23), 17846-17856.
91. Davis-Dusenbery, B. N.; Chan, M. C.; Reno, K. E.; Weisman, A. S.; Layne, M. D.; Lagna, G.; Hata, A. Down-regulation of Kruppellike factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J. Biol. Chem. 2011, 286(32), 28097-28110.
92. Wang, Z.; Li, Y.; Kong, D.; Sarkar, F. H. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr. Drug Targets 2010, 11(6), 745-751.
93. Timmerman, L. A.; Grego-Bessa, J.; Raya, A.; Bertrán, E.; Pérez-Pomares, J. M.; Díez, J.; Aranda, S.; Palomo, S.; McCormick, F.; Izpisúa-Belmonte, J. C.; de la Pompa, J. L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18(1), 99-115.
94. Li, I. C.; Chan, C. T.; Lu, Y. F.; Wu, Y. T.; Chen, Y. C.; Li, G. B.; Lin, C. Y.; Hwang, S. P. Zebrafishkruppel-like factor 4a represses intestinal cell proliferation and promotes differentiation of intestinal cell lineages. PLoS One 2011, 6(6), e20974.
95. Lambertini, C.; Pantano, S.; Dotto, G. P. Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes. PLoS One 2010, 5(4), e10369.
96. Liu, Z.; Teng, L.; Bailey, S. K.; Frost, A. R.; Bland, K. I.; LoBuglio, A. F.; Ruppert, J. M.; Lobo-Ruppert, S. M. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biol. Ther. 2009, 8(19), 1840-1851.
97. Ghaleb, A. M.; Aggarwal, G.; Bialkowska, A. B.; Nandan, M. O.; Yang, V. W. Notch inhibits expression of the Kruppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol. Cancer Res. 2008, 6(12), 1920-1927.
98. Sarkar, F. H.; Li, Y.; Wang, Z.; Kong, D. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev. 2010, 29(3), 383-394.
99. Schmalhofer, O.; Brabletz, S.; Brabletz, T. E-cadherin, betacatenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009, 28(1-2), 151-166.
100. Sellak, H.; Wu, S.; Lincoln, T. M. KLF4 and SOX9 transcription factors antagonize beta-catenin and inhibit TCF-activity in cancer cells. Biochim. Biophys. Acta. 2012, 1823(10), 1666-1675.
101. Stone, C. D.; Chen, Z. Y.; Tseng, C. C. Gut-enriched Kruppel-like factor regulates colonic cell growth through APC/beta-catenin pathway. FEBS Lett. 2002, 530(1-3), 147-152.
102. Zhang, W.; Chen, X.; Kato, Y.; Evans, P. M.; Yuan, S.; Yang, J.; Rychahou, P. G.; Yang, V. W.; He, X.; Evers, B. M.; Liu, C. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell Biol. 2006, 26(6), 2055-2064.
103. Evans, P. M.; Chen, X.; Zhang, W.; Liu, C. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by betacatenin. Mol Cell Biol. 2010, 30(2), 372-381.